Purging Multiple Myeloma Cells from Blood Stem Cells
Author Information
Author(s): Deola Sara, Scaramuzza Samantha, Birolo Roberto, Cergnul Massimiliano, Ficara Francesca, Dando Jonathan, Voena Claudia, Vai Sergio, Monari Marta, Pogliani Enrico, Corneo Gianmarco, Peccatori Jacopo, Selleri Silvia, Bordignon Claudio, Roncarolo Maria Grazia, Aiuti Alessandro, Bregni Marco
Primary Institution: San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Scientific Institute H.S. Raffaele, Milan, Italy
Hypothesis
Can a novel culture-based method effectively purge tumor contaminants from myeloma apheresis?
Conclusion
The study demonstrates that ex-vivo culture and retroviral transduction can efficiently purge tumor cells from myeloma leukaphereses.
Supporting Evidence
- Overall recovery of CD34+ cells after culture was 128.5%.
- ΔNGFR transduction rate was 28.8% for CD34+ cells.
- Recovery of CD34+ cells after ΔNGFR selection was 22.3%.
- Decreased tumor load was observed after CD34+ cell selection.
Takeaway
Researchers found a way to clean cancer cells out of blood stem cells, which helps patients with multiple myeloma get better treatment.
Methodology
The study involved culturing myeloma-positive CD34+ PB samples and using retroviral transduction to select for healthy cells.
Limitations
The study did not achieve complete elimination of myeloma contaminants.
Participant Demographics
Patients with multiple myeloma undergoing high-dose chemotherapy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website